Introduction
Materials and methods
Study design and patients
Study procedures
Irreversible electroporation
Robot-assisted radical prostatectomy
Complication, quality of life and early oncological control evaluation
Analysis
Quality of life comparison
Matching criteria and statistical analysis
Results
Patient and matching characteristics
Variable | IRE | RARP | Match (p value) |
---|---|---|---|
Age (years) | 67 (62–73) | 67 (64–71) | Yes (p = 0.953) |
PSA (μg/L) | 5.9 (3.3–7.3) | 6.3 (4.3–7.7) | Yes (p = 0.229) |
Prostate volume (cc) | 35 (30–50) | 37.5 (27–50) | |
Clinical stage | |||
T1c | 37 | 34 | |
T2a | 12 | 14 | |
T2b | 1 | 2 | |
Biopsy (ISUP) | |||
1 | 8 | 9 | |
2 | 33 | 31 | |
3 | 9 | 10 | |
Average ISUP | 2 (2–2) | 2 (2–2) | Yes (p = 0.997) |
# of cores taken | 22 (10–29) | 19 (14–31) | |
# of positive cores | 4.0 (2.8–5.3) | 4.0 (3.0–7.0) | Yes (p = 0.189) |
Baseline function | |||
EPIC urinary | 92 (79–98) | 91 (83–96) | Yes (p = 0.920) |
EPIC sexual | 65 (48–81) | 69 (41–79) | Yes (p = 0.820) |
EPIC bowel | 96 (93–100) | 96 (93–98) | Yes (p = 0.756) |
SF-12 physical | 56 (52–57) | 55 (52–58) | Yes (p = 0.588) |
SF-12 mental | 57 (50–58) | 56 (51–59) | Yes (p = 0.807) |
AUA | 6 (3–13) | 7 (3–11) | Yes (p = 0.978) |
Erections sufficient for intercourse | 69% (34/49) | 68% (34/50) | Yes (p = 0.882) |
Pad-free continence rate | 98% (49/50) | 98% (49/50) | Yes (p = 1.000) |